Patel Sanj K
SEC insider (Form 3/4/5 filer). CIK 0001532218. CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA). 89 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in LONDON.
Companies Patel Sanj K has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Director, Officer, CHAIRMAN & CEO
Patel Sanj K
CIK: 0001532218
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kiniksa Pharmaceuticals International, plc
Discretionary Trading P&L
Holdings
Transaction History (89 total)
- Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseIndirect6.2K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentIndirect15.1K shares at avg. $79.28$1.2M - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
30.1K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseIndirect8.6K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseIndirect6.5K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
120.2K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseIndirect10K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
30.1K shares- - Sep 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
120.2K shares- - Jun 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ConversionIndirect900K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 6,237 | - | $0 | Indirect |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 15,144 | $79.28 | $1,200,616 | Indirect |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 30,050 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 8,609 | - | $0 | Indirect |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 6,481 | - | $0 | Indirect |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 120,150 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 9,991 | - | $0 | Indirect |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 30,050 | - | - | Direct |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 120,150 | - | - | Direct |
| Jun 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Conversion | 900,000 | - | $0 | Indirect |
1-10 of 89 transactions